Gut colonization of healthy children and their mothers with pathogenic ciprofloxacin-resistant Escherichia coli

Journal of Infectious Diseases

Volumn 212, Issue 12, 2015, Pages 1862-1868

  Gurnee, Emily A ^a,d   Ndao, I Malick ^a   Johnson, James R ^b   Johnston, Brian D ^b   Gonzalez, Mark D ^a   Burnham, Carey Ann D ^a   Hall Moore, Carla M ^a   McGhee, Jessica E ^a,e   Mellmann, Alexander ^c   Warner, Barbara B ^a   Tarr, Phillip I ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e ST JOHN S MERCY MEDICAL CENTER   (United States)

Author keywords

Ciprofloxacin resistant E. coli; E. coli ST131 H30; E. coli ST405; Extra intestinal pathogenic E. coli; Urinary tract infections

Indexed keywords

CIPROFLOXACIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHILD; CHILD PARENT RELATION; COHORT ANALYSIS; CONTROLLED STUDY; EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; HOSPITALIZATION; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; ADULT; DRUG EFFECTS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; GASTROINTESTINAL TRACT; GENOTYPE; HETEROZYGOTE; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR TYPING; NEWBORN; NORMAL HUMAN; PREGNANCY; PRESCHOOL CHILD; PREVALENCE;

ADULT; ANTI-BACTERIAL AGENTS; CARRIER STATE; CHILD, PRESCHOOL; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; GASTROINTESTINAL TRACT; GENOTYPE; HEALTHY VOLUNTEERS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MOLECULAR TYPING; PREGNANCY; PREVALENCE; PROSPECTIVE STUDIES;

EID: 84943663356     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv278     Document Type: Article

References (38)

1. Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev 2014; 27:543-74.
2. Peirano G, Ahmed-Bentley J, Fuller J, Rubin JE, Pitout JD. Travel-related carbapenemase-producing Gram-negative bacteria in Alberta, Canada: the first 3 years. J Clin Microbiol 2014; 52:1575-81.
3. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 2011; 66:1-14.
4. Qin X, Razia Y, Johnson JR, et al. Ciprofloxacin-resistant gram-negative bacilli in the fecal microflora of children. Antimicrob Agents Chemo-ther 2006; 50:3325-9.
5. Gurnee EA, Ndao IM, McGhee JE, et al. Fecal carriage of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in healthy children. Antimicrob Agents Chemother 2014; 58:1261-2.
6. Wirth T, Falush D, Lan R, et al. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 2006; 60:1136-51.
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 23rd informational supplement. Wayne, PA: CLSI, 2013.
8. Johnson JR, Clermont O, Johnston B, et al. Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131. J Clin Microbiol 2014; 52:1358-65.
9. Han JH, Johnston B, Nachamkin I, et al. Clinical and molecular epidemiology of Escherichia coli sequence type 131 (ST131) among hospitalized patients colonized intestinally with fluoroquinolone-resistant E. coli. Antimicrob Agents Chemother 2014; 58:7003-6.
10. Banerjee R, Johnson JR. A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob Agents Chemo-ther 2014; 58:4997-5004.
11. Pitout JD. Extraintestinal pathogenic Escherichia coli: a combination of virulence with antibiotic resistance. Front Microbiol 2012; 3:9.
12. Coque TM, Novais A, Carattoli A, et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis 2008; 14:195-200.
13. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008; 61:273-81.
14. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious mul-tidrug-resistant E. coli infections in the United States. Clin Infect Dis 2010; 51:286-94.
15. Assimacopoulos A, Johnston B, Clabots C, Johnson JR. Post-prostate biopsy infection with Escherichia coli ST131 leading to epididymo-orchitis and meningitis caused by Gram-negative bacilli. J Clin Micro-biol 2012; 50:4157-9.
16. Bert F, Johnson JR, Ouattara B, et al. Genetic diversity and virulence profiles of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis. J Clin Microbiol 2010; 48:2709-14.
17. Vigil KJ, Johnson JR, Johnston BD, et al. Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis 2010; 50:374-80.
18. Johnson JR, Tchesnokova V, Johnston B, et al. Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J Infect Dis 2013; 207:919-28.
19. Chandramohan L, Revell PA. Prevalence and molecular characterization of extended-spectrum-beta-lactamase-producing Enterobacteria-ceae in a pediatric patient population. Antimicrob Agents Chemother 2012; 56:4765-70.
20. Weissman SJ, Adler A, Qin X, Zerr DM. Emergence of extended-spectrum beta-lactam resistance among Escherichia coli at a US academic children's hospital is clonal at the sequence type level for CTX-M-15, but not for CMY-2. Int J Antimicrob Agents 2013; 41: 414-20.
21. Johnson JR, Anderson JT, Clabots C, Johnston B, Cooperstock M. Within-household sharing of a fluoroquinolone-resistant Escherichia coli sequence type ST131 strain causing pediatric osteoarticular infection. Pediatr Infect Dis J 2010; 29:473-5.
22. Woods KL, Johnson JR, Padkowsky S, et al. Community-associated Escherichia coli harboring CTX-M beta-lactamases from urine cultures from pediatric patients. Antimicrob Agents Chemother 2012; 56:2209-10.
23. Cheng MF, Chen WL, Hung WY, et al. Emergence of extended spectrum-β-lactamase-producing Escherichia coli O25b-ST131: a major community-acquired uropathogen in infants. Pediatr Infect Dis J 2015; 34: 469-75.
24. Severin JA, Lestari ES, Kloezen W, et al. Faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae among humans in Java, Indonesia, in 2001-2002. Trop Med Int Health 2012; 17: 455-61.
25. Nicolas-Chanoine MH, Gruson C, Bialek-Davenet S, et al. 10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum beta-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre. J Antimicrob Chemother 2013; 68:562-8.
26. Nuesch-Inderbinen MT, Abgottspon H, Zurfluh K, Nuesch HJ, Stephan R, Hachler H. Cross-sectional study on fecal carriage of Enterobacteria-ceae with resistance to extended-spectrum cephalosporins in primary care patients. Microb Drug Resist 2013; 19:362-9.
27. Hilty M, Betsch BY, Bogli-Stuber K, et al. Transmission dynamics of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting. Clin Infect Dis 2012; 55:967-75.
28. Blanc V, Leflon-Guibout V, Blanco J, et al. Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains. J Antimicrob Chemother 2014; 69:1231-7.
29. Mihaila L, Wyplosz B, Clermont O, et al. Probable intrafamily transmission of a highly virulent CTX-M-3-producing Escherichia coli belonging to the emerging phylogenetic subgroup D2 O102-ST405 clone. J Anti-microb Chemother 2010; 65:1537-9.
30. Olesen B, Frimodt-Moller J, Leihof RF, et al. Temporal trends in antimicrobial resistance and virulence-associated traits within the escherichia coli sequence type 131 clonal group and its H30 and H30-Rx subclones, 1968 to 2012. Antimicrob Agents Chemother 2014; 58:6886-95.
31. Colpan A, Johnston B, Porter S, et al. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin Infect Dis 2013; 57:1256-65.
32. Sannes MR, Kuskowski MA, Owens K, Gajewski A, Johnson JR. Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia and uninfected control subjects. J Infect Dis 2004; 190:2121-8.
33. Rodriguez-Bano J, Mingorance J, Fernandez-Romero N, et al. Virulence profiles of bacteremic extended-spectrum beta-lactamase-producing Es-cherichia coli: association with epidemiological and clinical features. PLoS One 2012; 7:e44238.
34. Lillo J, Pai K, Balode A, et al. Differences in extended-spectrum beta-lactamase producing Escherichia coli virulence factor genes in the Baltic Sea region. Biomed Res Int 2014; 2014:427254.
35. Cheng CH, Tsau YK, Kuo CY, Su LH, Lin TY. Comparison of extended virulence genotypes for bacteria isolated from pediatric patients with urosepsis, acute pyelonephritis, and acute lobar nephronia. Pediatr Infect Dis J 2010; 29:736-40.
36. Santos AC, Zidko AC, Pignatari AC, Silva RM. Assessing the diversity of the virulence potential of Escherichia coli isolated from bacteremia in Sao Paulo, Brazil. Braz J Med Biol Res 2013; 46:968-73.
37. Yamamoto S, Tsukamoto T, Terai A, Kurazono H, Takeda Y, Yoshida O. Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli. J Urol 1997; 157: 1127-9.
38. Gruneberg RN, Leigh DA, Brumfitt W. Relationship of bacteriuria in pregnancy to acute pyelonephritis, prematurity, and fetal mortality. Lancet 1969; 2:1-3.